Month: May 2021

Nicosia, Cyprus, May 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to officially announce the launch of its brand-new website and domain, designed with a user-friendly navigation, updated with the latest information and topics about its products and services. Its company goal with the new website is to provide its customers and shareholders an easier way to learn about the company. Rafina’s team will be constantly updating the company’s content with helpful information, articles and company announcements. https://www.vicahub.com Rafina Innovations Inc.is pleased to announce that it has entered into an Exclusive Distribution Agreement with OPTEC International, Inc., a developer of UV and UV-C safety products using related...

VANCOUVER, British Columbia, May 17, 2021 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE, OTCQX: SKREF) (“Skeena” or the “Company”) is pleased to announce that it has closed its previously announced bought deal public offering (the “Offering”). Pursuant to the Offering, Skeena issued a total of 18,548,388 common shares (the “Common Shares”), at a price of C$3.10 per Common Share for gross proceeds to the Company of approximately C$57.5 million. This total includes 2,419,355 Common Shares issued in connection with the full exercise of the 15% over-allotment option granted to the Underwriters in connection with the Offering. The Offering was completed through a syndicate of underwriters co-led by Raymond James Ltd. and Canaccord Genuity Corp., and including Clarus Securities Inc., RBC Dominion Securities Inc., Sprott Capital...

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN CANADA NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, reported results for the first quarter ended March 31, 2021. The company will hold a conference call at 1:00 p.m. Eastern time today to discuss the results (see dial-in information below).   Q1 2021 Financial HighlightsRevenue for the first quarter increased 23% sequentially to $8.1 million, driven by a $1.1 million increase to a record $5.6 million in revenue by DataLogiq due to strong growth in data monetization, and $328,000 increase in revenue by AppLogiq as a shift to higher margin direct sales gained traction. Consolidated gross profit as a percentage of revenue in the first quarter increased to 27.6%, up 647 basis points sequentially...

NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Nasdaq CM:MRM), a Japanese based holistic healthcare Company (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of April 2021. The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of April 2021.The number of salons was 301 in April 2021, up from 290 in the year-ago period, primarily as a result of openings of new salons. Total customers served were 63,682 in April 2021 versus 13,381 in April 2020, a 376% increase due to a recovery from the COVID-19 impact. Sales per customer slightly decreased to JPY 6,250 in April 2021, up from JPY6,209 in April 2020. The decrease from the previous month is due to promotional pricing for the...

Company announcement no. 09 / 2021Schindellegi, Switzerland – 17 May 2021 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL This announcement does not constitute an offering memorandum or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017. The offer to acquire securities pursuant to any offering will be made, and any investor should make his investment decision, solely on the basis of information that is contained in a prospectus to be made generally available in Denmark in connection with the offering. Copies of the prospectus may be obtained by persons in Denmark through the website of the Company as set forth elsewhere in...

TORONTO, May 17, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM) (OTCQB: PHRRF), a psychedelics biotech company, is pleased to announce that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Investigational New Drug (“IND”) application to proceed with a Phase 2 clinical trial to evaluate the safety, efficacy and pharmacokinetics of ketamine in the treatment of levodopa-induced dyskinesia in patients with Parkinson’s disease (“LID-PD”).   PharmaTher expects to begin enrolling patients in the Phase 2 clinical trial in Q3-2021. Assuming the Phase 2 clinical trial is positive, the Company will request a meeting with the FDA to discuss its plan and obtain an agreement to move to a Phase 3 clinical study under the 505(b)(2) regulatory pathway next year. Fabio Chianelli,...

MONTREAL, May 17, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes plasma atomized metal powders, environmentally friendly plasma waste-to-energy systems and clean plasma torch products, is pleased to announce today its financial and operational results for the first quarter ended March 31st, 2021. “We are happy to be announcing that our Q1 2021 financial results continue to reflect the historical trend set early last year. The last several quarters saw PyroGenesis more than triple its backlog of signed contracts, reduce debt to basically zero, and recording over $25 million of cash on the balance sheet. All this, while graduating to...